| SEGMENT INFORMATION |
NOTE
20 – SEGMENT INFORMATION
For
the three and six months ended June 30, 2019 and 2018, the Company operated in three reportable business segments - (1) the real
property operating segment, (2) the medical related consulting services segment, and (3) the performing development services for
hospitals and other customers and sales of developed products to hospitals and other customers segment. The Company's reportable
segments are strategic business units that offer different services and products. They are managed separately based on the fundamental
differences in their operations. Information with respect to these reportable business segments for the three and six months ended
June 30, 2019 and 2018 was as follows:
| |
|
Three Months |
|
Three Months |
|
Six Months |
|
Six Months |
| |
|
Ended |
|
Ended |
|
Ended |
|
Ended |
| |
|
June 30,
2019 |
|
June 30,
2018 |
|
June 30,
2019 |
|
June 30,
2018 |
| Revenues |
|
|
|
|
|
|
|
|
| Real property operating |
|
$ |
264,889 |
|
|
$ |
278,872 |
|
|
$ |
531,515 |
|
|
$ |
575,495 |
|
| Medical related consulting services – related party |
|
|
111,434 |
|
|
|
141,996 |
|
|
|
125,694 |
|
|
|
141,996 |
|
| Development services and sales of developed products |
|
|
23,404 |
|
|
|
75,225 |
|
|
|
26,682 |
|
|
|
86,515 |
|
| |
|
|
399,727 |
|
|
|
496,093 |
|
|
|
683,891 |
|
|
|
804,006 |
|
| Depreciation and amortization |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Real property operating |
|
|
40,780 |
|
|
|
32,625 |
|
|
|
81,561 |
|
|
|
65,249 |
|
| Medical related consulting services |
|
|
4,766 |
|
|
|
3,991 |
|
|
|
7,706 |
|
|
|
7,997 |
|
| Development services and sales of developed products |
|
|
100,443 |
|
|
|
87,980 |
|
|
|
195,853 |
|
|
|
174,729 |
|
| |
|
|
145,989 |
|
|
|
124,596 |
|
|
|
285,120 |
|
|
|
247,975 |
|
| Interest expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Real property operating |
|
|
8,819 |
|
|
|
24,932 |
|
|
|
32,877 |
|
|
|
261,918 |
|
| Medical related consulting services |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Development services and sales of developed products |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
| |
|
|
8,819 |
|
|
|
24,932 |
|
|
|
32,877 |
|
|
|
261,918 |
|
| Net income (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Real property operating |
|
|
(3,690 |
) |
|
|
5,617 |
|
|
|
(102,379 |
) |
|
|
(232,083 |
) |
| Medical related consulting services |
|
|
(54,627 |
) |
|
|
16,456 |
|
|
|
(244,697 |
) |
|
|
(157,018 |
) |
| Development services and sales of developed products |
|
|
(230,406 |
) |
|
|
(196,896 |
) |
|
|
(478,188 |
) |
|
|
(297,028 |
) |
| Other (a) |
|
|
(4,150,100 |
) |
|
|
(1,168,992 |
) |
|
|
(8,118,488 |
) |
|
|
(2,208,655 |
) |
| |
|
$ |
(4,438,823 |
) |
|
$ |
(1,343,815 |
) |
|
$ |
(8,943,752 |
) |
|
$ |
(2,894,784 |
) |
| Identifiable long-lived
tangible assets at June 30, 2019 and December 31, 2018 |
|
June
30,
2019 |
|
|
December
31, 2018 |
|
| Real
property operating |
|
$ |
7,810,549 |
|
|
$ |
7,898,224 |
|
| Medical related
consulting services |
|
|
3,417 |
|
|
|
6,852 |
|
| Development
services and sales of developed products |
|
|
371,489 |
|
|
|
224,364 |
|
| |
|
$ |
8,185,455 |
|
|
$ |
8,129,440 |
|
| Identifiable long-lived
tangible assets at June 30, 2019 and December 31, 2018 |
|
June
30,
2019 |
|
|
December 31,
2018 |
|
| United
States |
|
$ |
7,907,804 |
|
|
$ |
7,898,806 |
|
| China |
|
|
277,651 |
|
|
|
230,634 |
|
| |
|
$ |
8,185,455 |
|
|
$ |
8,129,440 |
|
|
(a) |
The
Company does not allocate any interest expense and general and administrative expense
of its being a public company activities to its reportable segments as these activities
are managed at a corporate level. |
|